Page last updated: 2024-10-25

ciprofloxacin and Myringosclerosis

ciprofloxacin has been researched along with Myringosclerosis in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Myringosclerosis: The formation of dense connective tissue in the TYMPANIC MEMBRANE that does not necessarily cause or lead to loss of hearing.

Research Excerpts

ExcerptRelevanceReference
" Our objective is to evaluate the effectiveness of ciprofloxacin in the prevention of myringosclerosis that is created by myringotomy in rats and to compare it with prednisolone."7.78Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis. ( Arslan, N; Caydere, M; Demirci, M; Oguz, H; Taştan, E; Tepe, D; Ustun, H, 2012)
" Our objective is to evaluate the effectiveness of ciprofloxacin in the prevention of myringosclerosis that is created by myringotomy in rats and to compare it with prednisolone."3.78Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis. ( Arslan, N; Caydere, M; Demirci, M; Oguz, H; Taştan, E; Tepe, D; Ustun, H, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arslan, N1
Tepe, D1
Taştan, E1
Demirci, M1
Caydere, M1
Ustun, H1
Oguz, H1

Other Studies

1 other study available for ciprofloxacin and Myringosclerosis

ArticleYear
Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2012, Volume: 269, Issue:11

    Topics: Administration, Topical; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Di

2012